Drug Trial Radar · NCT00259350
Chlorhexidine vs Povidone Iodine in Alcoholic Solutions for Prevention of Central Venous Catheter Infection
Last checked: Nov 19, 2026Latest source record: Jan 27, 2009 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
520
Actual
Start
May 2004
Primary completion
Not stated
Study completion Apr 2006
Sponsor
- Lead sponsor
- Poitiers University HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 29, 2005
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The best antiseptic solution for cateheter care remains unknown.High concentration in aquous solution or low concentration in alcoholic solution of chlorhexidine actbetter than povidone iodine in aquous solutions. No study has compare alcoholic formulations of low concentration of chlorhexidine and povidone iodine for skin disinfection prior to insertion of central venous catheters. To compare the incidence of central venous catheter colonization after skin disinfection with either an alcoholic solution of povidone iodine or a combination of 0.5% chlorhexidine, 0.025% Benzalkonium and 4% benzylic alcohol. To compare the incidence of catheter related bacteremia in the to study groups. To compare the local and general tolerance of the two antiseptic formulations
Conditions
- ICU Patients Requiring a Central Venous Access
Interventions
Skin disinfectionDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Prevention of catheter colonization
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University hospital
Poitiers, Vienne, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.